News

World Class Hospitals Join DNA Damage Response Consortium to Bring Forward New Treatments for Adults and Children with Brain Cancer Researchers from St. Jude Children’s Research Hospital, NYU, UCSF, and the University of Minnesota join National Brain Tumor Society and Yale-led Initiative   Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced new partners for its DNA Damage Response Consortium. Joining the initiative are world-class experts in adult and pediatric neuro-oncology […] March 28, 2023

Introducing the Jumpstarting Brain Tumor Drug Development Coalition We first told you about our Clinical Trial Endpoints Initiative back in late June of 2013. We then let the Chair of the Initiative’s Steering Committee, Dr. Patrick Wen of Dana-Farber Cancer Institute, explain the promise of this effort further in a video interview we posted back in December. Now, we’d like to introduce you […] January 28, 2014

Advancing Research to Therapies Conference Connects Field National Brain Tumor Society hosted the inaugural Advancing Research to Therapies (ART) for Brain Tumors Conference in Washington, D.C. during Brain Tumor Awareness Month in May 2013. The ART Conference brought together more than 100 leading experts from academic research labs, government agencies, biotech and pharmaceutical companies, and venture capital firms to discuss faster commercialization […] July 23, 2013